Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Henry Schein (NASDAQ:HSIC) in the last three months. The table below summarizes their recent ...

Revenue: US$12.7b (up 2.7% from FY 2023). Net income: US$390.0m (down 6.2% from FY 2023). Profit margin: 3.1% (down from 3.4% in FY 2023). The decrease in margin was driven by higher expenses. EPS ...

MELVILLE, N.Y.--(BUSINESS WIRE)--In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting ...

“For five years, Henry Schein has had the privilege of spotlighting promising athletic trainers through the Rising Star program,” said Eric Kearns, National Sales Director of Henry Schein ...

2025 Total Sales Growth Guidance: Expected to be 2% to 4% over 2024. Henry Schein Inc (NASDAQ:HSIC) achieved 41% of its total operating income from high-growth, high-margin businesses in 2024.

MELVILLE, N.Y. - Henry Schein has simplified its organizational structure and appointed Andrea Albertini and Tom Popeck to lead its three business groups as part of its 2025 to 2027 BOLD+1 Strategic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported ...

Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “We have confidence in the underlying fundamentals of our business and look forward to advancing the opportunities contained ...